^
BRCA2 mutation
Prostate Cancer
BRCA1 mutation
Prostate Cancer
No biomarker
Follicular Lymphoma
No biomarker
Diffuse Large B Cell Lymphoma
No biomarker
Mediastinal B Cell Lymphoma
No biomarker
NSCLC
MSI-H/dMMR
CRC
No biomarker
HCC
PD-L1 overexpression
NSCLC
PD-L1 overexpression
NSCLC
MET exon 14 mutation
NSCLC
No biomarker
Multiple Myeloma
EZH2 mutation
Follicular Lymphoma
FGFR2 rearrangement
Cholangiocarcinoma
FGFR2 fusion
Cholangiocarcinoma
PD-L1 overexpression
NSCLC
No biomarker
Cervical Cancer
No biomarker
Cervical Cancer
No biomarker
Pancreatic Cancer
EGFR exon 20 insertion
NSCLC
EGFR exon 20 insertion
NSCLC
HR positive
HER2 Negative Breast Cancer
HR positive
HER2 Negative Breast Cancer
MSI-H/dMMR
Solid Tumor
MSI-H/dMMR
CRC
MSI-H/dMMR
Gastric Cancer
HR positive
HER2 Negative Breast Cancer
WDR5 overexpression
Bladder Cancer
HER-2 positive
HER2 Positive Breast Cancer
BRCA2 mutation
Prostate Cancer
KRAS G12C
NSCLC
EGFR mutation
NSCLC
No biomarker
AML
No biomarker
Neuroendocrine Tumor
No biomarker
Waldenstrom Macroglobulinemia
TMB-H
Osteosarcoma
HR positive
HER2 Negative Breast Cancer
HR positive
HER2 Negative Breast Cancer
No biomarker
Esophageal Squamous Cell Carcinoma
MSI-H/dMMR
CRC
BRAF V600E
NSCLC
No biomarker
Multiple Myeloma
BRCA1 mutation
HER2 Negative Breast Cancer
BRCA2 mutation
HER2 Negative Breast Cancer
No biomarker
Glioma
No biomarker
Gastroesophageal Junction Adenocarcinoma
No biomarker
Gastric Cancer
No biomarker
Mantle Cell Lymphoma
EGFR mutation
NSCLC
Chr t(11;14)
Multiple Myeloma
No biomarker
Cervical Cancer
ALK fusion
NSCLC
HER-2 positive
HER2 Positive Breast Cancer
No biomarker
Melanoma
No biomarker
Prostate Cancer
PD-L1 expression
NSCLC
BRCA1 mutation
Ovarian Serous Adenocarcinoma
HER-2 negative
Gastric Cancer
EGFR mutation
NSCLC
SLC22A1 1222AG
CML
SLCO1B3 334TT
CML
SLCO1B3 334TG
CML
SLCO1B3 334T
CML
SLC22A1 480CC + SLC22A1 1222AG + SLCO1B3 334TT + SLCO1B3 334TG
CML
BRAF mutation
Melanoma
EGFR expression
NSCLC
HR positive
HER2 Negative Breast Cancer
PD-L1 negative
Merkel Cell Carcinoma
YWHAE-ROS1 fusion
Soft Tissue Sarcoma
BCR-ABL1 T315I
NHL
BRAF S365L
NSCLC
KIF5B-EGFR fusion
NSCLC
H3.3K27M
Glioma
CLTC-ALK fusion
Diffuse Large B Cell Lymphoma
BRCA1 mutation
Solid Tumor
BRCA2 mutation
Solid Tumor
BTK C481S + MYD88 mutation
Lymphoma
No biomarker
Diffuse Large B Cell Lymphoma
No biomarker
NSCLC
ALK positive
NSCLC
No biomarker
RCC
PD-L1 expression
NSCLC
RET fusion
NSCLC
RET fusion
NSCLC
RET fusion
Thyroid Gland Carcinoma
Chr del(17p)
CLL
TP53 mutation
CLL
BRCA1 mutation
Ovarian Cancer
BRCA2 mutation
Ovarian Cancer
No biomarker
Prostate Cancer
No biomarker
AML
No biomarker
Multiple Myeloma
No biomarker
Gastroesophageal Junction Adenocarcinoma
No biomarker
Gastric Cancer
RET mutation
Thyroid Gland Medullary Carcinoma
No biomarker
Follicular Lymphoma
Chr del(17p)
CLL
Chr del(17p)
CLL
No biomarker
CLL
EGFR mutation
NSCLC
No biomarker
Nasopharyngeal Carcinoma
TP53 mutation
CLL
TP53 mutation
CLL
HER-2 positive
HER2 Positive Breast Cancer
EGFR mutation
NSCLC
PD-L1 expression
Gastroesophageal Junction Adenocarcinoma
PD-L1 expression
Gastric Cancer
FGF21-H
HCC
PD-L1 expression
Esophageal Adenocarcinoma
HER-2 positive
HER2 Positive Breast Cancer
Chr del(17p)
CLL
SF3B1 mutation
CLL
BIRC3 mutation
CLL
NOTCH1 mutation
CLL
ATM mutation
CLL
Chr del(11q)
CLL
No biomarker
B Acute Lymphoblastic Leukemia
AXL positive
NSCLC
VEGFA-H
HCC
No biomarker
GBM
BRAF V600
Ganglioglioma
BRAF V600
Glioma
BRAF V600
Ganglioglioma
BRAF V600
Glioma
CD20 positive
Diffuse Large B Cell Lymphoma
TP53 mutation + Chr del(17p)
CLL
TP53 mutation
CLL
CD20 positive
Diffuse Large B Cell Lymphoma
CD20 positive
Follicular Lymphoma
NECTIN4 expression
Urothelial Cancer
ER mutation
HER2 Negative Breast Cancer
EGFR mutation
NSCLC
Chr del(11q)
CLL
EZH2 mutation
Follicular Lymphoma
CD20 overexpression
Diffuse Large B Cell Lymphoma
PD-L1 expression
NSCLC
TP53 mutation
CLL
EGFR mutation
NSCLC
TP53 mutation + Chr del(17p)
Small Lymphocytic Lymphoma
Chr del(17p)
Small Lymphocytic Lymphoma
TP53 mutation
Small Lymphocytic Lymphoma
TP53 mutation + Chr del(17p)
CLL
Chr del(17p)
CLL
Chr del(11q)
CLL
Chr del(17p)
CLL
MYC rearrangement
NHL
HER-2 positive
HER2 Positive Breast Cancer
HER-2 positive
HER2 Positive Breast Cancer
TDO2 overexpression
Bladder Cancer
MCM4 overexpression
Liposarcoma
MYC rearrangement + BCL2 rearrangement
Diffuse Large B Cell Lymphoma
MYC rearrangement + BCL2 rearrangement + BCL6 rearrangement
Diffuse Large B Cell Lymphoma
PD-L1 expression
NHL
TMB-H + HER-2 positive
HER2 Positive Breast Cancer
MTHFR C677T
CRC
MTHFR C677T
CRC
MTHFR C677T
CRC
MTHFR C677T
CRC
PD-L1 expression
Melanoma
CD20 positive
Mantle Cell Lymphoma
PAX5 mutation
Diffuse Large B Cell Lymphoma
CREBBP mutation
Diffuse Large B Cell Lymphoma
EP300 mutation
Diffuse Large B Cell Lymphoma
TBX21 overexpression
Diffuse Large B Cell Lymphoma
PD-L1 amplification
Diffuse Large B Cell Lymphoma
IGH mutation + Chr del(13q)
CLL
SOCS1 mutation
Diffuse Large B Cell Lymphoma
IRF8 mutation
Diffuse Large B Cell Lymphoma
CD19 mutation
Diffuse Large B Cell Lymphoma
TP53 overexpression
Mantle Cell Lymphoma
TP53 mutation
Small Lymphocytic Lymphoma
Chr del(17p)
Small Lymphocytic Lymphoma
IGH mutation + Chr del(11q)
CLL
TP53 mutation
Mantle Cell Lymphoma
CD58 mutation
Diffuse Large B Cell Lymphoma
TIGIT overexpression
Diffuse Large B Cell Lymphoma
HAVCR2 expression
Follicular Lymphoma
Chr del(17p)
Small Lymphocytic Lymphoma
TP53 mutation
CLL
Chr del(17p)
CLL
MYC rearrangement + BCL2 rearrangement
Diffuse Large B Cell Lymphoma
MYC rearrangement + BCL6 rearrangement
Diffuse Large B Cell Lymphoma
TP53 deletion
CLL
TP53 mutation
Small Lymphocytic Lymphoma
EGFR exon 19 deletion + PD-L1 overexpression
LUAD
CCND3 T283A
AML
CCND3 Q276* + CCND3 S264R
AML
MRPS9-ALK fusion
LUAD
EML4-ALK fusion + NFKBIA amplification + NKX2-1 amplification
NSCLC
EGFR exon 19 mutation + EGFR C797S + PIK3CA mutation
NSCLC
FLT3-ITD mutation
AML
BIRC5 mutation
GBM
miR-27a-3p overexpression
HCC
ALK positive
T Cell Non-Hodgkin Lymphoma
MYD88 mutation
Diffuse Large B Cell Lymphoma
MYD88 mutation
Diffuse Large B Cell Lymphoma
MYD88 mutation
Diffuse Large B Cell Lymphoma
EGFR exon 19 deletion
NSCLC
ALK positive
NSCLC
EGFR T790M
NSCLC
HER-2 positive
HER2 Positive Breast Cancer
No biomarker
Malignant Pleural Mesothelioma
EGFR L858R
NSCLC
PD-L1 overexpression
NSCLC
HER-2 positive
HER2 Positive Breast Cancer
FGFR2 rearrangement
Cholangiocarcinoma
FGFR2 fusion
Cholangiocarcinoma
HRD
Ovarian Cancer
No biomarker
Multiple Myeloma
BRAF V600
Melanoma
No biomarker
Multiple Myeloma
No biomarker
Lung Non-Small Cell Squamous Cancer
FLT3-ITD mutation
AML
No biomarker
Clear Cell Renal Cell Carcinoma
PD-L1 expression
Urothelial Cancer
No biomarker
Multiple Myeloma
No biomarker
Multiple Myeloma
No biomarker
NSCLC
RET fusion
LUAD
FGFR2 fusion
Cholangiocarcinoma
BRAF mutation
Melanoma
MAGEA4 expression
Sarcoma
IDH2 mutation
Glioma
IDH1 mutation
Glioma
ER positive
Breast Cancer
CDKN2A mutation
Urothelial Cancer
BCR-ABL1 fusion
ALL
KMT2A rearrangement
AML
CDCA3 overexpression
NSCLC
CDCA3 overexpression
NSCLC
ER overexpression
Estrogen Receptor Positive Breast Cancer
IDH2 mutation + ALK fusion
NSCLC
PIK3CA mutation + ALK fusion
NSCLC
ALK fusion + ALK G1202R
NSCLC
ALK fusion + EGFR exon 19 deletion + BRAF G466V + MAP2K1 F129L
NSCLC
ALK fusion + ALK G1269A
NSCLC
PD-L1 expression
Triple Negative Breast Cancer
MSI-H/dMMR + PD-L1 expression
Neuroendocrine Tumor
HER-2 negative
HER2 Negative Breast Cancer
AR elevation
Prostate Cancer
DDR
Soft Tissue Sarcoma
SAMHD1 expression
Ovarian Cancer
SAMHD1 expression
NSCLC
SAMHD1 expression
Breast Cancer
SAMHD1 expression
Ovarian Cancer
SAMHD1 expression
Ovarian Cancer
Chr del(17p) + Chr del(11q)
CLL
Chr del(11q)
CLL
Chr del(17p)
CLL
HER-2 positive + CAV1 overexpression
Gastric Cancer
IL10 overexpression
Breast Cancer
MAD2L2 underexpression
Soft Tissue Sarcoma
XRCC2 underexpression
Soft Tissue Sarcoma
RAD54L underexpression
Soft Tissue Sarcoma
BLM underexpression
Soft Tissue Sarcoma
APEX2 underexpression
Soft Tissue Sarcoma
ATM overexpression
Soft Tissue Sarcoma
SLFN11 overexpression
Soft Tissue Sarcoma
PIK3R1 overexpression
Soft Tissue Sarcoma
CDKN2A overexpression
Soft Tissue Sarcoma
ER expression
NSCLC
CLDN18-ARHGAP fusion
Gastric Cancer
TLR4-L
Bladder Cancer
ALK fusion + MYC amplification + CCND1 deletion + FGFR3 deletion
NSCLC
MSI-H/dMMR + TMB-H + PD-L1 overexpression
Pancreatic Ductal Adenocarcinoma
AFP elevation + VIM positive
Sarcoma
PD-L1 overexpression + MET exon 14 mutation
LUAD
EGFR D770_N771insSVD
LUAD
HER-2 positive
Gastric Cancer
HR positive
Ovarian Cancer
miR-34a expression
Triple Negative Breast Cancer
HOXA11 overexpression
AML
EGFR L747P
LUAD
EGFR exon 19 deletion + BRAF G464A
LUAD
PD-L2 overexpression
Endometrial Cancer
ATM underexpression
Prostate Cancer
BRCA1 underexpression
Prostate Cancer
CYP3A4 overexpression
Soft Tissue Sarcoma
CYP3A5 underexpression
Soft Tissue Sarcoma
CD133 positive
GBM
BRCA2 underexpression
Prostate Cancer
EPAS1 overexpression
HCC
CD44 positive
GBM
HER-2 exon 20 insertion
LUAD
ATRX mutation
GBM
HIF1A overexpression
HCC
BST1 positive
AML
ATRX deletion
Glioma
EML4-ALK variant 3
NSCLC
miR-518d-5p overexpression
HCC
SRC overexpression + BRAF V600E
CRC
IDH2 R172G
Sarcoma
PTCH1 mutation
CRC
CDH1 expression
Colon Cancer
ALK positive
Neuroblastoma
No biomarker
Multiple Myeloma
CD20 positive
CLL
EGFR exon 19 deletion
NSCLC
No biomarker
NSCLC
EGFR exon 19 deletion
NSCLC
PD-L1 expression
Triple Negative Breast Cancer
EGFR L858R
NSCLC
HER-2 positive
HER2 Positive Breast Cancer
KIT positive
GIST
HER-2 positive
HER2 Positive Breast Cancer
ALK fusion
NSCLC
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
PDGFRA D842V
GIST
No biomarker
Gastroesophageal Junction Adenocarcinoma
No biomarker
Fallopian Tube Cancer
No biomarker
Ovarian Cancer
No biomarker
Peritoneal Cancer
No biomarker
Mantle Cell Lymphoma
PD-L1 expression
NSCLC
No biomarker
Esophageal Adenocarcinoma
No biomarker
NHL
ALK positive
NSCLC
ROS1 fusion
NSCLC
No biomarker
Gastric Cancer
HER-2 positive
HER2 Positive Breast Cancer
MET exon 14 mutation
NSCLC
No biomarker
NSCLC
ALK positive
NHL
No biomarker
NSCLC
EGFR L858R
NSCLC
No biomarker
Small Cell Lung Cancer
EGFR T790M
NSCLC
EGFR exon 19 deletion
NSCLC
MET exon 14 mutation
NSCLC
FLT3 mutation
AML
PD-L1 overexpression
NSCLC
No biomarker
SCCHN
No biomarker
Gastric Adenocarcinoma
No biomarker
Gastroesophageal Junction Adenocarcinoma
No biomarker
NSCLC
No biomarker
NSCLC
No biomarker
Breast Cancer
No biomarker
BCC
PD-L1 expression
Urothelial Cancer
EGFR L858R
NSCLC
No biomarker
Lung Non-Squamous Non-Small Cell Cancer
No biomarker
Multiple Myeloma
No biomarker
Thyroid Gland Medullary Carcinoma
ALK positive
NSCLC
No biomarker
NSCLC
ROS1 positive
NSCLC
EGFR mutation
NSCLC
No biomarker
Lung Non-Squamous Non-Small Cell Cancer
No biomarker
Small Cell Lung Cancer
HER-2 positive
Gastric Cancer
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
BRCA2 mutation
Pancreatic Cancer
PD-L1 expression
NSCLC
IDH2 mutation
AML
No biomarker
AML
EGFR mutation
NSCLC
No biomarker
HCC
No biomarker
HCC
No biomarker
Multiple Myeloma
No biomarker
Multiple Myeloma
No biomarker
Multiple Myeloma
BRCA1 mutation
Pancreatic Cancer
No biomarker
Diffuse Large B Cell Lymphoma
No biomarker
Lymphoma
No biomarker
Diffuse Large B Cell Lymphoma
No biomarker
B Acute Lymphoblastic Leukemia
No biomarker
Childhood B Acute Lymphoblastic Leukemia
No biomarker
Prostate Cancer
No biomarker
CLL
No biomarker
SCCHN
No biomarker
NSCLC
No biomarker
Gastric Cancer
No biomarker
Urothelial Cancer
BRCA1 mutation
Peritoneal Cancer
No biomarker
Multiple Myeloma
No biomarker
Gastroesophageal Junction Adenocarcinoma
No biomarker
SCCHN
PD-L1 expression
Gastroesophageal Junction Adenocarcinoma
HER-2 positive
HER2 Positive Breast Cancer
No biomarker
AML
HER-2 positive
Gastric Cancer
BRAF V600
Melanoma
BRAF V600E
CRC
BRAF V600E
CRC
No biomarker
Soft Tissue Sarcoma
No biomarker
Colon Cancer
No biomarker
CLL
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our